Combination therapy with sorafenib and celecoxib for pediatric patients with desmoid tumor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination therapy with sorafenib and celecoxib for pediatric patients with desmoid tumor

Published:2020-03-04 Issue:5 Volume:37 Page:445-449
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Robles Joanna¹,Keskinyan Vahakn S.²,Thompson Matthew³,Davis Joseph T.⁴,Mater David Van¹

Affiliation:

1. Department of Pediatrics, Division of Pediatric Hematology-Oncology, Duke University Medical Center, Durham, NC, USA;

2. Department of Pediatrics, Duke University Medical Center, Durham, NC, USA;

3. Department of Radiology, Wake Forest Baptist Hospital, Winston-Salem, NC, USA;

4. Department of Radiology, Duke University Medical Center, Durham, NC, USA

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2020.1735591

Reference21 articles.

1. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

2. Desmoid Tumors

3. A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses

4. Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor

5. Desmoid-Type Fibromatosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorafenib-Induced Capillary Leak Syndrome;Case Reports in Oncology;2023-10-11

2. Desmoid fibromatosis in the pharyngeal wall: A case report and literature review;Clinical Case Reports;2022-01

3. Pursuing Precision: Receptor Tyrosine Kinase Inhibitors for Treatment of Pediatric Solid Tumors;Cancers;2021-07-14

4. Evaluating Solubility of Celecoxib in Age-Appropriate Fasted- and Fed-State Gastric and Intestinal Biorelevant Media Representative of Adult and Pediatric Patients: Implications on Future Pediatric Biopharmaceutical Classification System;AAPS PharmSciTech;2021-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3